RxSight, Inc. - Common Stock (RXST)
7.3800
+0.1000 (1.37%)
NASDAQ · Last Trade: Jul 17th, 10:18 PM EDT
Detailed Quote
Previous Close | 7.280 |
---|---|
Open | 7.330 |
Bid | 7.280 |
Ask | 7.450 |
Day's Range | 7.210 - 7.420 |
52 Week Range | 6.320 - 58.23 |
Volume | 1,483,883 |
Market Cap | 250.79M |
PE Ratio (TTM) | -11.01 |
EPS (TTM) | -0.7 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,948,263 |
Chart
About RxSight, Inc. - Common Stock (RXST)
Rxsight Inc is a healthcare technology company that focuses on enhancing vision correction through its innovative approach to personalized refractive surgery. The company develops advanced systems that utilize sophisticated algorithms and proprietary software to optimize intraocular lenses for patients undergoing cataract surgery. By combining data-driven insights with precision eye care, Rxsight aims to improve visual outcomes for patients, ultimately advancing the standards of treatment in the ophthalmic field. Their commitment to personalized medicine is reflected in their ongoing research and development efforts to create more effective solutions for vision-related challenges. Read More
News & Press Releases
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into RxSight, Inc. (NASDAQ: RXST) for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · July 17, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · July 16, 2025
Law Offices of Howard G. Smith continues its investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · July 16, 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In RxSight (RXST) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 15, 2025
SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · July 15, 2025
The Law Offices of Frank R. Cruz continues its investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Frank R. Cruz · Via Business Wire · July 15, 2025
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · July 11, 2025
Law Offices of Howard G. Smith announces an investigation on behalf of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · July 11, 2025
The Law Offices of Frank R. Cruz announces an investigation of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · July 10, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · July 9, 2025
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
Via Benzinga · July 9, 2025
RxSight Inc. (RXST) shares plunged 34.32% in after-hours. The decline to $8.40 follows a downward revision of its 2025 revenue forecast.
Via Benzinga · July 9, 2025
Via Benzinga · July 8, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · July 8, 2025